mRNA compartmentalization via multimodule DNA nanostructure assembly augments the immunogenicity and efficacy of cancer mRNA vaccine
Science Advances · 22.11.2024 · 10 (47)
DOI: 10.1126/sciadv.adp3680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 22.11.2024. Verfasst von Xiaocui Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: New Cornerstone Science Laboratory, CAS Key Laboratory of Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanosci…. Hauptthemen laut MEDLINE: RNA, Messenger, Cancer Vaccines, Nanostructures, mRNA Vaccines. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Messenger RNA (mRNA) vaccine has fueled a great hope for cancer immunotherapy. However, low immunogenicity, caused by inefficient mRNA expression and weak immune stimulation, hampers the efficacy of mRNA vaccines. Here, we present an mRNA compartmentalization–based cancer vaccine, comprising a multimodule DNA nanostructure (MMDNS)–assembled compartment for efficient mRNA translation via in situ localizing mRNA concentration and relevant reaction molecules. The MMDNS is constructed via programmable DNA hybridization chain reaction (HCR)–based strategy, with integrating antigen-coded mRNA, CpG oligodeoxynucleotides (ODNs), acidic-responsive DNA sequence, and dendritic cells targeting aptamer. MMDNS undergoes in situ assembly in acidic lysosomes to form a micro-sized aggregate, inducing an enhanced CpG ODN adjuvant efficacy. Subsequently, the aggregates escape into cytoplasm, providing a moderate compartment which supports the efficient translation of spatially proximal mRNA transcripts via localizing relevant reaction molecules. The mRNA compartmentalization–based vaccine boosts a strong immune response and effectively inhibits tumor growth and metastasis, offering a robust strategy for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- New Cornerstone Science Laboratory, CAS Key Laboratory of Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing…
- Health Management Institute, The Second Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- GBA National Institute for Nanotechnology Innovation, Guangzhou, 510700, China.
ORCID-Profile: Xiaocui Guo, Mengyu Guo, Rong Cai, Wen Su, Jing Liu, Chunying Chen
Zitieren
APA
Guo, X., Guo, M., Cai, R., Hu, M., Rao, L., Su, W., Liu, H., Gao, F., Zhang, X., Liu, J., & Chen, C. (2024). mRNA compartmentalization via multimodule DNA nanostructure assembly augments the immunogenicity and efficacy of cancer mRNA vaccine. Science Advances, 10(47). https://doi.org/10.1126/sciadv.adp3680
Vancouver
Guo X, Guo M, Cai R, Hu M, Rao L, Su W, et al. mRNA compartmentalization via multimodule DNA nanostructure assembly augments the immunogenicity and efficacy of cancer mRNA vaccine. Science Advances. 2024;10(47). doi:10.1126/sciadv.adp3680
BibTeX
@article{Guo2024,
author = {Guo, Xiaocui and Guo, Mengyu and Cai, Rong and Hu, Mingdi and Rao, Le and Su, Wen and Liu, He and Gao, Fene and Zhang, Xiaoyu and Liu, Jing and Chen, Chunying},
title = {mRNA compartmentalization via multimodule DNA nanostructure assembly augments the immunogenicity and efficacy of cancer mRNA vaccine},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {47},
doi = {10.1126/sciadv.adp3680}
}
EUVIMED